Ains-To investigate the heterotypic adhesion of unactivated platelets to chemotactically responsive (migrated) and non-responsive (non-migrated) polymorphonuclear neutrophils (PMN). Methods-Platelets and PMN were isolated from autologous, normal blood. Migrated and non-migrated PMN were separated after N-formylmethionyl-leucylphenylalanine (FMLP) stimulation. Platelets were labelled with a fluorescent monoclonal antibody directed against CD41 (GPITb-IIIa). Platelets (3 x 10n/ml) and PMN (3 x 106/ml) were incubated together. 
Platelet-polymorphonuclear neutrophil (PMN) adhesion is a dynamic process which contributes to haemostasis and inflammation. In vitro studies show that platelet-PMN interactions have stimulatory and inhibitory effects on the function of both cell types. Cell-cell contact as well as soluble inhibitors seem to be involved in platelet-PMN interactions,'2 but the mechanisms of these heterotypic interactions have yet to be elucidated. Activated platelet adhesion to PMN is calcium dependent and is mediated by P-selectin (CD62P)3-s expressed on the activated platelet surface binding to the leucocyte P-selectin glycoprotein ligand-1L. Unactivated platelets also bind to PMN when platelets and PMN are incubated together.7 However, the binding is independent of divalent cations and may be mediated by a platelet receptor other than P-selectin. 7 PMN exhibit heterogeneous chemotactic responsiveness in vitro. One subpopulation migrates rapidly in response to a chemoattractant gradient, whereas the other subpopulation fails to migrate.89 Cell surface adhesion molecule expression is downregulated differentially on migrated PMN.'°In the present study we have characterised the adhesion ofunactivated platelets to migrated and non-migrated PMN by flow cytometry and obtained supportive microscopic evidence of platelet-PMN interaction.
Methods

PLATELET PREPARATION
Platelets were isolated from normal blood collected in anticoagulant citrate dextrose solution (75 mM trisodium citrate, 38 mM citric acid, 124 mM dextrose). To obtain platelet rich plasma, blood was centrifuged at 160 x g for 20 minutes at room temperature (20-24°C) . Washed, unactivated platelets were obtained from platelet rich plasma by being centrifuged at 1000 x g for 10 minutes and suspended at a density of 3 x 1 08/ml in Tyrode's/HEPES buffer (TH; 137-0 mM NaCl, 2-7 mM KCI, 042 mM NaH2PO4, 12-5 mM NaHCO,, 2-0 mM MgCl2, 5-5 mM D-glucose, 5-0 mM HEPES, and 3-5 mg/ml bovine serum albumin, pH 7A4) containing 2 4°C , and analysed by flow cytometry. For the divalent cation depletion study, 2 mM EDTA (Sigma) was added to each cell fraction for 20 minutes before co-incubation.
FLOW CYTOMETRY
A FACScan flow cytometer (Becton Dickinson) was used to acquire light scatter and fluorescence signals for at least 10 000 events from each sample. Gating on platelet events and PMN events was performed using forward and side scatter, with FITC conjugated CD41 monoclonal antibody as a platelet specific marker, and PE conjugated CD45 monoclonal antibody as a PMN specific marker. Results are expressed as histograms of cell count versus log fluorescence intensity (FL1-H). Non-specific binding, obtained from parallel assays with FITC or PE labelled isotype control monoclonal antibody, was used to set a threshold marker for positive platelet fluorescence. The marker excluded 99% of the isotype control fluorescence. The percentage ofactivated platelets in the platelet preparations was determined by the proportion of FITC conjugated CD4 1 positive particles also expressing greater than background levels of CD62P (P-selectin, activation dependent surface antigen released from cx-granules) estimated using the PE conjugated CD62P monoclonal antibody. The platelet fluorescence ratio, an estimate of the number of platelets bound to each PMN, was determined as described previously,7 from the ratio of the mean platelet marker fluorescence in the PMN gate to the mean platelet marker fluorescence in the platelet gate. The experiments were performed at least four times with a single representative experiment shown in figs 1 fig 1. PMN events (fig 1A) , positive for FITC conjugated CD4 1, represent PMN with bound platelets. The marker shown in figs lB-IF is set such that it excludes 99% of the isotype control (fig 1 B) fig 3B, filled histogram) . number of platelets (7%) expressing low levels 3C-3F, the percentages of of CD62P in the unactivated platelet prenulated, migrated, and non-paration. The percentages of migrated and nonith attached platelets are sim-migrated PMN with bound platelets after coas true when all four ex-incubation were similar. This adherence occompared (no statistical curred in the absence of divalent cations. open bars). EDTA had no
The adherence of platelets to unactivated ing of PMN to platelets (data and activated PMN differs, the latter being to two platelets were bound mediated by platelet CD62P (P-selectin) and s measured by the platelet PMN P-selectin glycoprotein ligand-1. The percentage of PMN with attached, unactivated platelets in the present study is higher than that CROSCOPY reported previously. heterotypic cell adhesion and their relevance in inflammation and haemostasis remain to be elucidated.
